Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oren-gedoku-to (also known as Huanglian-Jiedu-Tang) is a traditional Japanese Kampo medicine composed of four medicinal herbs: Coptis Rhizome, Scutellaria Root, Phellodendron Bark, and Gardenia Fruit. It is traditionally used to treat inflammatory conditions, hypertension, gastritis, and various skin disorders. In modern clinical research, it is being investigated for its potential to prevent rebleeding in patients with colonic diverticular bleeding (CDB). The formulation contains several bioactive alkaloids and flavonoids, such as berberine, palmatine, baicalin, and geniposide, which contribute to its anti-inflammatory, anti-oxidative, and vascular-stabilizing effects. It is regulated as a pharmaceutical product in Japan and is typically administered as oral granules.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oren-gedoku-to.